Please Wait.....
Report
Europe Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
Market Report I 2022-10-07 I 139 Pages I The Insight Partners
The influenza vaccines market in Europe is expected to grow from US$ 2,261.85 million in 2022 to US$ 3,424.02 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2022 to 2028.
Increasing Investment by Top Market Players and Governments
Market players and governments are increasing their investments in vaccine development and immunization. In June 2021, The European Investment Bank signed a US$ 30.55 million global vaccine distribution agreement with biotech company Univercells to mass produce the COVID-19 vaccine at a new Belgian site. It helped build other vaccine factories around the region. In April 2022, the Bank provided a US$ 15.27 million loan to Italian biomedical research company IRBM to expand its vaccine production capacity and strengthen research on coronaviruses and other diseases. Thus, the increase in investment by top market players and governments is bolstering the influenza vaccines market.
Market Overview
Europe is the second largest market in the forecast period owing to factors such as rising geriatric population, increasing prevalence of flu and related illness, and high demand for the development of new vaccines in the region. In addition, growing funding for research & development activities is likely to add more opportunities in coming years, in the region. The pharmaceutical industry is continuously expanding in the UK. Under the UK's pharmaceutical industry, over 610 companies are operating. According to Office National Statistics, 610 companies were operating in the UK in 2018. It has over 15 global companies headquartered in the UK. Also, nearly 41% of pharmaceutical production is exported to other countries and regions. Companies such as Astra Zeneca, Eli Lilly, and GSK have contributed significantly to the growth of pharmaceuticals and led research and development at a peak. The growth of these companies and expansions in the business segments is expected to influence market growth in the following years. The seasonal influenza vaccination programme was introduced in England during the late 1960s to protect those in clinical risk groups. During 2020 to 2021 an expanded offer was made which enabled people aged 50 to 64 years to receive the flu vaccine as part of an NHS funded programme. This offer will continue for this age group, as a temporary measure, for the 2021 to 2022 programme. Thus, the factors mentioned above are driving the market growth of influenza vaccines.
Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Europe Influenza Vaccines Market Segmentation
The Europe Influenza Vaccines Market is segmented into vaccine type, virus type, technology, route of administration, and country.
Based on vaccine type, the Europe influenza vaccines market is divided into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered the larger market share in 2022.
Based on virus type, the Europe influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger market share in 2022.
Based on technology, the Europe influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger market share in 2022.
Based on route of administration, the Europe influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger market share in 2022.
Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, and the rest of Europe. The UK dominated the market share in 2022.
AstraZeneca; Emergent BioSolutions Inc.; GlaxoSmithKline plc.; Hualan Biological Engineering Inc.; Mitsubishi Chemical Group Corporation; Moderna, Inc.; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the influenza vaccines market in Europe.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Influenza Vaccines Market - By Vaccine Type
1.3.2 Europe Influenza Vaccines Market - By Virus Type
1.3.3 Europe Influenza Vaccines Market - By Technology
1.3.4 Europe Influenza Vaccines Market - By Route Of Administration
1.3.5 Europe Influenza Vaccines Market - By Country
2. Europe Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Influenza Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Influenza Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market - Europe Analysis
6.1 Europe Influenza Vaccines Market Revenue Forecasts And Analysis
7. Europe Influenza Vaccines Market- By Vaccine Type
7.1 Overview
7.2 Europe Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. Europe Influenza Vaccines Market- By Virus Type
8.1 Overview
8.2 Europe Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Influenza Vaccines Market - By Technology
9.1 Overview
9.2 Europe Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.3 Egg-Based
9.3.1 Overview
9.3.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-Based
9.4.1 Overview
9.4.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Influenza Vaccines Market- By Route of Administration
10.1 Overview
10.2 Europe Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.3 Injection
10.3.1 Overview
10.3.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Influenza Vaccines Market - Country Analysis
11.1 Europe: Influenza Vaccines Market
11.1.1 Overview
11.1.2 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
11.1.2.1 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.1.1 Overview
11.1.2.1.2 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
11.1.2.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
11.1.2.1.5 Germany: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
11.1.2.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.2.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.2.1 Overview
11.1.2.2.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
11.1.2.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
11.1.2.2.5 UK: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
11.1.2.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.2.3 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.3.1 Overview
11.1.2.3.2 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
11.1.2.3.4 France: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
11.1.2.3.5 France: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
11.1.2.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.2.4 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.4.1 Overview
11.1.2.4.2 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
11.1.2.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
11.1.2.4.5 Italy: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
11.1.2.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.2.5 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.5.1 Overview
11.1.2.5.2 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
11.1.2.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
11.1.2.5.5 Spain: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
11.1.2.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
11.1.2.6 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.6.1 Overview
11.1.2.6.2 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
11.1.2.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
11.1.2.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
11.1.2.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
11.1.2.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
12. Europe Influenza Vaccine Market -Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Moderna, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 SEQIRUS
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sanofi
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 GlaxoSmithKline plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hualan Biological Engineering Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Emergent BioSolutions Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mitsubishi Chemical Group Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Serum Institute of India Pvt. Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 MYLAN N.V.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 AstraZeneca
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 7. UK: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. UK Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 10. France Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. France Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 13. France Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 18. Spain Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Europe Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 26. Recent Inorganic Growth Strategies in the Europe Influenza Vaccine Market
Table 27. Recent Organic Growth Strategies in the Europe Influenza Vaccine Market
Table 28. Glossary of Terms, Europe Influenza Vaccines Market
LIST OF FIGURES
Figure 1. Europe Influenza Vaccines Market Segmentation
Figure 2. Europe Influenza Vaccines Market Segmentation, by Country
Figure 3. Europe Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Europe Influenza Vaccines Market
Figure 5. UK Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. Europe: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis
Figure 10. Europe Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 11. Europe Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 12. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 15. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 18. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 21. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Europe Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 25. Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security